Guillermo (Bill) Martinez

Objective

My objectives are to employ Lean Six Sigma tools and years of management experience in the Healthcare setting to meet the needs of customers.

ExperienceDec. 2010 - PresentCreative Testing Solutions, Inc., St. Petersburg, FL.Technical Director – DTL (full-time hours worked) Provide technical and administrative direction to a staff of 50 dedicated technologists

working in a highly automated donor-testing laboratory performing approximately 15,000,000 tests per year for over 40 different clients.

Collaborate with the Medical Director and the Quality Department to achieve the highest degree of regulatory compliance (no 483 forms in the last three FDA inspections).

Developed a training program for Medical Technologists in 2012. The program is licensed by the State of Florida.

Trained staff in Operational Excellence and the Shingo Principles. Helped improve lab operations by removing excess motion of samples and people. Research coordinator of a protocol evaluating the specificity of the cobas Zika test for the

detection of Zika virus in homologous blood donors (protocol No. cX8-ZIKA-412). Research coordinator of a protocol evaluating a system for the detection of Dengue virus

RNA in plasma specimens from individual human donors, including volunteer donors of whole blood and, blood components and other living donors in the US and Puerto Rico (DENVTS-US12-002).

Research coordinator of protocols evaluating next generation WNV, HIV, HCV and HBV PCR assays from Roche Molecular Systems on the cobas 8800 system.

Research coordinator of protocols evaluating next generation PCR assays from Hologics using the Procleix Panther® system.

1990-Dec 2010 LifeSouth Community Blood Centers, Inc. Gainesville, FL.Technical Director (full-time hours worked) Provided technical and administrative direction to a staff of 24 team members working in a

highly automated donor-testing laboratory performing approximately 3,000,000 tests per year.

Provided technical and administrative direction to highly qualified staff of seven specialists who worked in a reference and quality control laboratory performing highly specialized immunohematology, hematology, molecular and flowcytometry assays.

Page 1 of 4

Achieve Office (727) 578-3226Cell (352) 275-4235E-mail Gam0811@yahoo.com

108 44th AVE NESt. Pete, FL. 33703

Developed LifeSouth’s training program for Medical Technologists in 2006. The program is licensed by the State of Florida, license number TP 258.

Developed LifeSouth’s bilingual translation services for blood donation Hired and retained a core group of outstanding managers, supervisors, and technical staff. Research coordinator and sub-investigator of a protocol determining the value of banking

cord blood for transplantation (BB-IND 7520). Research coordinator and sub-investigator of a protocol evaluating the use of TMA to

detect WNV in volunteer blood donors (2003BBWBWNV- 04) Research coordinator of a post-market study titled “Identification of Confirmed HBV Yield

Cases Using the PROCLEIX ULTRIO Assay in Blood Donations” Research coordinator and sub-investigator of protocols evaluating the use RT-PCR to

detect HIV (Protocol No: AS-HIV-046), and HCV in volunteer blood donors (Protocol No: AS-HCV-025)

Deputy Project Director for HRSA’s contract with LifeCord in support of the National Cord Blood Inventory HHSH234200867003C

Medical Technologist (full-time hours worked) 1986–1989 Veterans Administration Medical Center. Gainesville, FL General clinical lab duties

Medical Technologist (part-time 20 hours per pay period) 1987–1988 Shands Teaching Hospital. Gainesville, FL Part-time Blood Bank

1983–1986 Alachua General Hospital. Gainesville, FL (full-time hours worked) General clinical lab duties

1978–1982 US Navy Hospital Corpsman

Education1990–1994 University of Central Florida. Orlando, FL

MS, Health Services Administration

1982–1986 University of Florida. Gainesville FL

BS, Medical Technology

2016 - Villanova University on line Lean Six Sigma certificate. Pursuing Six Sigma Black Belt certification with emphasis in health care

Page 2 of 2

Skills Speak Spanish fluently.

Experienced user of MS Office software.

Knowledgeable of FDA, CMS, and OHRP regulations, as well as good laboratory practices, CAP and AABB Standards.

Yellow belt in Six Sigma.

Lean practitioner certificate from Villanova University

AffiliationsAmerican Society for QualityAmerican College of Health Care ExecutivesAmerican LegionAmerican Society of Clinical PathologistsAmerican Association of Blood Bank

Publications Abdel-Mageed A, del Rosario MLU, Hutcheson CE, Iturraspe JA, Martinez G, Roberts CG, Wingard JR: Effect of temperature variation and duration from collection to processing of umbilical HPC, cord blood units on cell number, viability, and clonogenic potential. Blood 90(10, Suppl 1):321b, Abstract #4194, 1997

Abdel-Mageed A, Hutcheson CE, Braylan RC, Metz SJ, Iturraspe JA, del Rosario MLU, Pardo PJ, Eckert N, Martinez G, Fisk DD, Sugrue MW, Roberts CF, Wingard JR: Feasibility of umbilical HPC, cord blood unit collection and processing for volume reduction and thawing: Effect on cell loss, viability, and clonogenic potential. Blood 90(10, Suppl 1):321b, Abstract #4195.Hubl, W. et. Al. Effect of Storage on Stem Cell Concentration and Viability in Cord Blood. ASH Abstract Submission.

Hubl W, Iturraspe J, Martinez GA, Hutcheson CE, Roberts CG, Fisk DD, Sugrue MW, Wingard JR, Braylan RC. Measurement of absolute concentration and viability of CD34+ cells in HPC, cord blood and HPC, cord blood products using fluorescent beads and cyanine nucleic acid dyes. Cytometry 1998; 34(3):121-127.

B. Martinez, et. Al. Comparative testing for weak expression of D antigen:

Page 3 of 2

manual tube testing vs. a semi-automated IgG gel system

G. Martinez, N. Haubert, G. Leparc, P. Williamson, R. Spizman, . Robertson G, S. Caglioti, J. Dunn-Williams, M. Dixon, Comparison of Reactive Rates Between EIA and Chemi- luminescent Donor Screening Assays. CONTROL ID: 2006291, AABB abstract 2013.

Evaluation of High Triglycerides Concentrations for Interference with Immucor’s DonorScreen-HLA® Assay. Guillermo Martinez1, Phillip C. Williamson, German F. Leparc, Jennifer Ritter, Sally Caglioti, Cheryl Amaral

Page 4 of 2